Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.
Saved in:
| Title: | Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study. |
|---|---|
| Authors: | Horvath N; Department of Haematology, Royal Adelaide Hospital , Adelaide , Australia., Spencer A; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia., Kenealy M; Cabrini Health, Australia and Monash University , Melbourne , Australia., Joshua D; Department of Haematology, Royal Prince Alfred Hospital , Camperdown , Australia, and Sydney University, Sydney, Australia., Campbell PJ; Department of Haematology, Andrew Love Cancer Centre , Geelong , Australia., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital , Hwasun , Republic of Korea., Hou J; Department of Hematology, Shanghai Changzheng Hospital , Shanghai , China., Qiu L; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Tianjin , China., Kalff A; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia., Khong T; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia., Londhe A; Janssen Research & Development LLC , Titusville , NJ , USA., Siggins S; Janssen Cilag , Sydney , Australia., van Kooten Losio M; Janssen Cilag , Sydney , Australia., Eisbacher M; Janssen Cilag , Sydney , Australia., Prince HM; Cabrini Health, Australia and Monash University , Melbourne , Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne , Melbourne , Australia. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2019 Sep; Vol. 60 (9), pp. 2122-2133. Date of Electronic Publication: 2019 Feb 19. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2019.1579322 |
